| Bos taurus |
Alpha-1a adrenergic receptor |
Ki |
0.1259 |
nM |
10.1021/jm970166j |
| Canis lupus familiaris |
Canis familiaris |
ID50 |
0.001 |
mg.kg-1 |
10.1021/jm960697s |
| Canis lupus familiaris |
Canis familiaris |
ID50 |
0.002 |
mg.kg-1 |
10.1021/jm960697s |
| Canis lupus familiaris |
Canis familiaris |
IUP |
8.87 |
None |
10.1021/jm990567u |
| Canis lupus familiaris |
Canis familiaris |
Kd |
0.2884 |
nM |
10.1021/jm990567u |
| Canis lupus familiaris |
Canis familiaris |
Kd |
1.349 |
nM |
10.1021/jm000541z |
| Canis lupus familiaris |
Canis familiaris |
Kd |
1.349 |
nM |
10.1021/jm970364a |
| Cavia porcellus |
Histamine H1 receptor |
Inhibition |
7.0 |
% |
10.1021/jm9905918 |
| Cavia porcellus |
Histamine H1 receptor |
Inhibition |
18.0 |
% |
10.1021/jm9905918 |
| Cavia porcellus |
Histamine H1 receptor |
Ki |
nan |
None |
10.1021/jm9905918 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adrenergic receptor alpha-1 |
Kd |
0.03981 |
nM |
10.1021/jm970166j |
| Homo sapiens |
Adrenergic receptor alpha-1 |
Kd |
0.1585 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Adrenergic receptor alpha-1 |
Kd |
6.31 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Adrenergic receptors; alpha-1 A & B |
Ratio |
1.4 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Adrenergic receptors; alpha-1 A & B |
Ratio |
14.8 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
1.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
EC50 |
0.07 |
nM |
10.1016/j.bmc.2016.09.017 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
FC |
1.6 |
None |
10.1016/j.ejmech.2017.03.036 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
FC |
1.6 |
None |
10.1039/C6MD00426A |
| Homo sapiens |
Alpha-1a adrenergic receptor |
IC50 |
0.32 |
nM |
10.1016/j.ejmech.2020.112616 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
IC50 |
2.2 |
nM |
10.1021/acs.jmedchem.6b01217 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Inhibition |
100.0 |
% |
10.1021/acs.jmedchem.6b01217 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Kd |
0.2884 |
nM |
10.1021/jm000541z |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Kd |
0.2884 |
nM |
10.1021/jm970364a |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.029 |
nM |
10.1021/jm970364a |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.05012 |
nM |
10.1016/j.ejmech.2010.09.042 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.13 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.19 |
nM |
10.1016/j.bmcl.2007.04.008 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.19 |
nM |
10.1016/j.bmcl.2007.04.098 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.19 |
nM |
10.1016/j.bmcl.2007.11.068 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.1995 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
0.2 |
nM |
10.1016/j.bmcl.2004.11.032 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
3.981 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ratio |
1.0 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
EC50 |
0.13 |
nM |
10.1016/j.bmc.2016.09.017 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
IC50 |
4.2 |
nM |
10.1016/j.ejmech.2020.112616 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
IC50 |
4.8 |
nM |
10.1021/acs.jmedchem.6b01217 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
0.61 |
nM |
10.1021/jm970364a |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
0.631 |
nM |
10.1016/j.ejmech.2010.09.042 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
1.259 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
1.92 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
2.0 |
nM |
10.1016/j.bmcl.2007.04.008 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
2.0 |
nM |
10.1016/j.bmcl.2007.04.098 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
2.0 |
nM |
10.1016/j.bmcl.2007.11.068 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
100.0 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
0.15 |
nM |
10.1016/j.ejmech.2020.112616 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
1.4 |
nM |
10.1021/acs.jmedchem.6b01217 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.058 |
nM |
10.1021/jm970364a |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.1 |
nM |
10.1016/j.ejmech.2010.09.042 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.1585 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.18 |
nM |
10.1021/acs.jmedchem.5b01528 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.18 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.2 |
nM |
10.1016/j.bmcl.2007.04.008 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.2 |
nM |
10.1016/j.bmcl.2007.04.098 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
0.2 |
nM |
10.1016/j.bmcl.2007.11.068 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
7.943 |
nM |
10.1021/jm960697s |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
790.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
4774.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Inhibition |
82.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
13.4 |
nM |
10.1021/jm970364a |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
63.0 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ratio |
490.0 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
1900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ratio |
620.0 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Inhibition |
41.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
7.9 |
nM |
10.1021/jm970364a |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
2500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
2200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2C9 |
FC |
1.0 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 2D6 |
FC |
6.7 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 3A4 |
FC |
1.0 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
Inhibition |
53.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D2 receptor |
Inhibition |
73.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
13.0 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
78.0 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D2 receptor |
Ratio |
100.0 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D2 receptor |
Ratio |
600.0 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
3.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
Inhibition |
109.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
0.28 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D3 receptor |
Ratio |
2.2 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine D4 receptor |
Inhibition |
21.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
6945.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
Selectivity ratio |
nan |
None |
10.1021/jm9905918 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-11.24 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.59 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
CL |
0.5 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
0.62 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
0.62 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.08 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
0.1 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fa |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
1.02 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.98 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.21 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
3800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
5300.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasma |
Fu |
0.01 |
None |
10.1039/C4MD00148F |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
20.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
Inhibition |
115.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
Ki |
0.79 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
Ratio |
6.1 |
None |
10.1021/jm9905918 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
14402.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
6400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
Inhibition |
74.0 |
% |
10.1021/jm9905918 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
Ki |
84.0 |
nM |
10.1021/jm9905918 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mesocricetus auratus |
Alpha-1b adrenergic receptor |
Ki |
0.2 |
nM |
10.1021/jm990567u |
| Mus musculus |
Alpha-1 adrenergic receptor |
IC50 |
1.8 |
nM |
10.1016/j.ejmech.2017.06.011 |
| Oryctolagus cuniculus |
Alpha-1a adrenergic receptor |
Kd |
0.1585 |
nM |
10.1021/jm970166j |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Kd |
0.3388 |
nM |
10.1021/jm000541z |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Kd |
0.3388 |
nM |
10.1021/jm970364a |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
0.03 |
nM |
10.1021/jm990567u |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
0.13 |
nM |
10.1016/j.ejmech.2011.04.032 |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
pKb |
9.46 |
None |
10.1016/j.ejmech.2010.09.042 |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Kd |
0.2042 |
nM |
10.1021/jm000541z |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Kd |
0.2042 |
nM |
10.1021/jm970364a |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
pKb |
9.3 |
None |
10.1016/j.ejmech.2010.09.042 |
| Rattus norvegicus |
Alpha-1d adrenergic receptor |
Kd |
0.02512 |
nM |
10.1021/jm970364a |
| Rattus norvegicus |
Alpha-1d adrenergic receptor |
Ki |
0.07 |
nM |
10.1021/jm990567u |
| Rattus norvegicus |
Alpha-1d adrenergic receptor |
pKb |
10.0 |
None |
10.1016/j.ejmech.2010.09.042 |
| Rattus norvegicus |
Alpha-2b adrenergic receptor |
Inhibition |
86.0 |
% |
10.1021/jm9905918 |
| Rattus norvegicus |
Alpha-2b adrenergic receptor |
Ki |
6.8 |
nM |
10.1021/jm970364a |
| Rattus norvegicus |
Alpha-2b adrenergic receptor |
Ki |
80.0 |
nM |
10.1021/jm9905918 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
36125.4 |
nM |
None |
| Rattus norvegicus |
Plasma |
Fu |
0.01 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Plasma |
Fu |
0.2 |
None |
10.1039/C4MD00148F |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmc.2016.09.017 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1021/acsmedchemlett.6b00225 |
| Rattus norvegicus |
Rattus norvegicus |
AD50 |
3.0 |
ug kg-1 |
10.1016/s0960-894x(99)00696-4 |
| Rattus norvegicus |
Rattus norvegicus |
AD50 |
3.0 |
ug kg-1 |
10.1021/jm990612y |
| Rattus norvegicus |
Rattus norvegicus |
Duration |
3.5 |
hr |
10.1021/jm990612y |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
11.0 |
% |
10.1016/j.bmc.2016.09.017 |
| Rattus norvegicus |
Rattus norvegicus |
Kd |
0.2042 |
nM |
10.1021/jm990567u |
| Rattus norvegicus |
Rattus norvegicus |
Kd |
0.3388 |
nM |
10.1021/jm990567u |
| Rattus norvegicus |
Rattus norvegicus |
pED50 |
7.33 |
None |
10.1021/jm000541z |
| Rattus norvegicus |
Rattus norvegicus |
pED50 |
7.33 |
None |
10.1021/jm970364a |
| Rattus norvegicus |
Rattus norvegicus |
pKB |
9.33 |
None |
10.1021/jm9905918 |
| Rattus norvegicus |
Rattus norvegicus |
pKB |
10.76 |
None |
10.1021/jm9905918 |
| Rattus norvegicus |
Rattus norvegicus |
SHR |
7.33 |
None |
10.1021/jm990567u |
| Rattus norvegicus |
Serotonin 1 (5-HT1) receptor |
Inhibition |
62.0 |
% |
10.1021/jm9905918 |
| Rattus norvegicus |
Serotonin 1 (5-HT1) receptor |
Ki |
944.0 |
nM |
10.1021/jm9905918 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel |
Inhibition |
20.0 |
% |
10.1021/jm9905918 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel |
Inhibition |
22.0 |
% |
10.1021/jm9905918 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel |
Ki |
nan |
nM |
10.1021/jm9905918 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
22.04 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1193 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.07 |
% |
10.6019/CHEMBL4495565 |
| None |
ADMET |
CL |
0.62 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
5.6 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Ratio EC50 |
1.93 |
None |
10.1016/j.bmc.2016.09.017 |
| None |
ADMET |
T1/2 |
6.8 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.21 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
nan |
None |
10.1016/j.drudis.2011.05.007 |
| None |
NON-PROTEIN TARGET |
Fu |
0.01 |
None |
10.1124/dmd.108.020479 |
| None |
Unchecked |
Inhibition |
64.0 |
% |
10.1021/jm9905918 |
| None |
Unchecked |
Ki |
0.0001 |
nM |
10.1016/j.ejmech.2010.09.042 |
| None |
Unchecked |
Ki |
1000.0 |
nM |
10.1016/j.ejmech.2010.09.042 |
| None |
Unchecked |
Ki |
10000000.0 |
nM |
10.1016/j.ejmech.2010.09.042 |
| None |
Unchecked |
Ratio |
0.5 |
None |
10.1021/jm960697s |
| None |
Unchecked |
Ratio |
0.6 |
None |
10.1021/jm000541z |
| None |
Unchecked |
Ratio |
26.9 |
None |
10.1021/jm9905918 |
| None |
Unchecked |
Ratio |
35.0 |
None |
10.1021/jm000541z |
| None |
Unchecked |
Ratio |
650.0 |
None |
10.1021/jm9905918 |
| None |
Unchecked |
Ratio |
7260.0 |
None |
10.1021/jm9905918 |
| None |
Unchecked |
Ratio |
nan |
None |
10.1021/jm9905918 |
| None |
Unchecked |
Ratio IC50 |
0.6 |
None |
10.1021/acs.jmedchem.6b01217 |
| None |
Unchecked |
Ratio IC50 |
2.2 |
None |
10.1021/acs.jmedchem.6b01217 |
| None |
Unchecked |
Ratio Ki |
0.7 |
None |
10.1021/acs.jmedchem.5b01528 |
| None |
Unchecked |
Ratio Ki |
11.0 |
None |
10.1021/acs.jmedchem.5b01528 |
| None |
Unchecked |
Ratio Ki |
14.8 |
None |
10.1016/j.ejmech.2011.04.032 |
| None |
Unchecked |
Selectivity ratio |
0.3 |
None |
10.1016/j.ejmech.2010.09.042 |
| None |
Unchecked |
Selectivity ratio |
1.5 |
None |
10.1016/j.ejmech.2010.09.042 |
| None |
Unchecked |
Selectivity ratio |
5.0 |
None |
10.1016/j.ejmech.2010.09.042 |